MSCRF Launch Program supports early-career faculty and established researchers new to human stem cell research, funding basic and translational work to understand and address human diseases and injuries.
Funder: Maryland Technology Development Corporation (TEDCO)
Due Dates: January 20, 2027, 5:00 p.m. EST (FY 2027 Round 2) | June 23, 2026, 5:00 p.m. EST (FY 2027 Round 1)
Funding Amounts: Up to $350,000 per award, including indirect costs, for up to two years
Summary: Supports early-career faculty and established researchers new to human stem cell research through innovative basic and translational projects in Maryland.
Key Information: The PI must not have received funding from any MSCRF program previously.
The Maryland Stem Cell Research Fund (MSCRF), administered by TEDCO, supports innovative human stem cell research and regenerative medicine through its Launch Program. The program helps researchers establish early academic careers and enables established faculty with expertise in other fields to enter stem cell research. It also encourages collaboration across schools, departments, academic institutions, and the public and private sectors.
Launch funds basic and translational research exploring new hypotheses, approaches, mechanisms, or models involving human stem cells, stem cell derivatives such as extracellular vesicles and secretome, or technologies that enable or support human stem cell research. Projects should advance understanding of human diseases, injuries, and conditions or contribute to prevention, diagnosis, treatment, and cure. Preliminary or proof-of-concept data are preferred but not required.